prevalence of arterial hypertension, associated diseases and end-organ damages in republic of bashkortostan

Clicks: 181
ID: 178288
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #73 of 98 articles by views in environmental technology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

Aim. To estimate arterial hypertension (AH) prevalence among population of Republic of Bashkortostan (RB), prevalence of end-organ damages and the associated clinical conditions in hypertensive patients.

Material and methods. 1648 people from 10 regions of RB were examined. Standard questionnaires were used - socially-demographic, health condition, WHO cardiologic questionnaire, women’s health.

Results. The urban and rural AH prevalence, AH prevalence in men and women, as well as AH comorbidities prevalence is studied. There is a high frequency of myocardial infarction and cerebral strokes in AH patients. Prevalence of end-organ damage and the associate clinical conditions is various in men and in women.

Сonclusion. Available data will help to develop primary and secondary AH prevention taking into account risk factors.

Reference Key
lukmanova2015racionalnaprevalence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;T. V. Lukmanova;I. M. Karamova;N. H. Sharafutdinova
Journal environmental technology
Year 2015
DOI
10.1234/1819-6446-2007-4-6-10
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.